{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:18:07Z","timestamp":1791141487748,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1331\/japha.2012.10114","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T04:24:30Z","timestamp":1326947070000},"page":"34-42","source":"Crossref","is-referenced-by-count":15,"title":["SF-6D utility index as measure of minimally important difference in health status change"],"prefix":"10.1016","volume":"52","author":[{"given":"Pranav K.","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Douglas","family":"Ried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bibbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2012.10114_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1331\/JAPhA.2012.10114_bb0015","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1331\/JAPhA.2012.10114_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0895-4356(99)00050-5","article-title":"Surveying physicians to determine the minimal important difference: implications for sample-size calculation","volume":"52","author":"van Walraven","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1331\/JAPhA.2012.10114_bb0025","article-title":"What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D","volume":"1","author":"Walters","year":"2003","journal-title":"Health Qual Life Outcomes."},{"key":"10.1331\/JAPhA.2012.10114_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1524-4733.2005.08202.x","article-title":"Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument","volume":"8","author":"Yost","year":"2005","journal-title":"Value Health"},{"key":"10.1331\/JAPhA.2012.10114_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status: ascertaining the minimally clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1331\/JAPhA.2012.10114_bb0040","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198606263142602","article-title":"The effects of antihypertensive therapy on the quality of life","volume":"314","author":"Croog","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1331\/JAPhA.2012.10114_bb0045","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(98)00423-9","article-title":"Rationale and design of the International Verapamil SR\/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension","volume":"32","author":"Pepine","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1331\/JAPhA.2012.10114_bb0050","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1331\/JAPhA.2012.10114_bb0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimally clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1331\/JAPhA.2012.10114_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1331\/JAPhA.2012.10114_bb0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.psy.0000160468.69451.7f","article-title":"A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST)","volume":"67","author":"Ried","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1331\/JAPhA.2012.10114_bb0070","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","author":"Joint National Committee on Prevention","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1331\/JAPhA.2012.10114_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ"},{"key":"10.1331\/JAPhA.2012.10114_bb0080","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0895-4356(98)00103-6","article-title":"Deriving a preference-based single index from the UK SF-36 health survey","volume":"51","author":"Brazier","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1331\/JAPhA.2012.10114_bb0085","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","article-title":"A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale","volume":"57","author":"Eton","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1331\/JAPhA.2012.10114_bb0090","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11162-009-9131-1","article-title":"A note on the calculation and interpretation of the delta-p statistic for categorical independent variables","volume":"50","author":"Cruce","year":"2009","journal-title":"Research in Higher Education"},{"key":"10.1331\/JAPhA.2012.10114_bb0095","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11136-007-9207-3","article-title":"Reliability, validity, and minimally important differences of the SF-6D in the systemic sclerosis","volume":"16","author":"Khanna","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1331\/JAPhA.2012.10114_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1081\/COPD-200050663","article-title":"Approaches and recommendations for estimating minimally important differences for health-related quality of life measures","volume":"2","author":"Hays","year":"2005","journal-title":"COPD"},{"key":"10.1331\/JAPhA.2012.10114_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.2044-8309.1995.tb01048.x","article-title":"Social comparisons as a mediator between health problems and subjective health evaluations","volume":"34","author":"VanderZee","year":"1995","journal-title":"Br J Soc Psychol"},{"key":"10.1331\/JAPhA.2012.10114_bb0110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/13607860802343241","article-title":"Living status and psychological well-being: social comparison as a moderator in later life","volume":"12","author":"Cheng","year":"2008","journal-title":"Aging Ment Health"},{"key":"10.1331\/JAPhA.2012.10114_bb0115","first-page":"269","article-title":"Do we know what global ratings of health-related quality of life measure? Qual Life Res","volume":"8","author":"Mozes","year":"1999"},{"key":"10.1331\/JAPhA.2012.10114_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1014485627744","article-title":"Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire","volume":"11","author":"Wyrwich","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1331\/JAPhA.2012.10114_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00451723","article-title":"Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia","volume":"3","author":"Jenkinson","year":"1994","journal-title":"Qual Life Res"},{"key":"10.1331\/JAPhA.2012.10114_bb0130","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0277-5379(83)90042-1","article-title":"Assessment of the quality of life of patients with advanced cancer","volume":"19","author":"Gough","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1331\/JAPhA.2012.10114_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific Quality of Life Questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115304271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115304271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T17:30:11Z","timestamp":1561224611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115304271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1544319115304271"],"URL":"https:\/\/doi.org\/10.1331\/japha.2012.10114","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}